mitoxantrone has been researched along with Adenocarcinoma, Endometrioid in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with stage I ovarian cancer show a high incidence of recurrent disease ranging from 30% to 50%, which may be associated with a shortened survival." | 1.31 | The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma. ( Aydiner, A; Bengisu, E; Berkman, S; Eralp, Y; Saip, P; Saliho, Y; Salihoğlu, Y; Taş, F; Topuz, E, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topuz, E | 1 |
| Eralp, Y | 1 |
| Saip, P | 1 |
| Aydiner, A | 1 |
| Taş, F | 1 |
| Saliho, Y | 1 |
| Salihoğlu, Y | 1 |
| Berkman, S | 1 |
| Bengisu, E | 1 |
1 other study available for mitoxantrone and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2001 |